scholarly journals Re-Admission Rates within 28 Days of Total Hip Replacement

2006 ◽  
Vol 88 (5) ◽  
pp. 475-478 ◽  
Author(s):  
C Cullen ◽  
DS Johnson ◽  
G Cook

INTRODUCTION The aim of the study was to identify the reasons for the higher than expected emergency re-admission to hospital within 28 days of total hip replacement (THR) for Stepping Hill Hospital, Stockport. PATIENTS AND METHODS Over a 42-month period, 65 (8.5%) of 769 patients were re-admitted within 28 days of discharge following primary THR. Case notes for 61 patients were available for retrospective review to assess premorbidity, initial postoperative complications and reason for re-admission. RESULTS The main reasons for re-admission were complications related to the procedure. These included thrombo-embolic disease 2.5%, atraumatic dislocation 1.4%, wound complications 1.2% and swollen limb 1.8%. Other causes such as admission to another department for problems not related to THR accounted for 0.8%. CONCLUSIONS Our findings are comparable with the published literature for early complications following THR. The three main reasons for re-admission were atraumatic dislocation, thrombo-embolic and wound complications such as superficial infection and haematoma are the commonest world-wide. The re-admission rate to hospital within the first 28 days following THR was a clinical indicator suggested by the UK Department of Health. It has subsequently been incorporated in a group of indicators used by the CASPE Healthcare Knowledge Systems (CHKS), a private healthcare consultancy and analysis company, for peer benchmarking. Our re-admission rates are inflated by admissions for non-THR-related reasons. The level of post-THR complications leading to re-admission were acceptable compared with the available published literature regarding 28-day re-admission. We anticipate that this study may act as a benchmark for other trusts.

2004 ◽  
Vol 14 (3) ◽  
pp. 155-162
Author(s):  
R. Mootanah ◽  
P. Ingle ◽  
K. Cheah ◽  
J. K. Dowell ◽  
J. C. Shelton

2013 ◽  
Vol 14 (1) ◽  
Author(s):  
Tosan Okoro ◽  
Ashok Ramavath ◽  
Jan Howarth ◽  
Jane Jenkinson ◽  
Peter Maddison ◽  
...  

2007 ◽  
Vol 17 (3) ◽  
pp. 155-159 ◽  
Author(s):  
H. Davies ◽  
J. Foote ◽  
R.F. Spencer

Restoration of hip biomechanics is a crucial component of successful total hip replacement. Preoperative templating is recommended to ensure that the size and orientation of implants is optimised. We studied how closely natural femoral offset could be reproduced using the manufacturers' templates for 10 femoral stems in common use in the UK. A series of 23 consecutive preoperative radiographs from patients who had undergone unilateral total hip replacement for unilateral osteoarthritis of the hip was employed. The change in offset between the templated position of the best-fitting template and the anatomical centre of the hip was measured. The templates were then ranked according to their ability to reproduce the normal anatomical offset. The most accurate was the CPS-Plus (Root Mean Square Error 2.0 mm) followed in rank order by: C stem (2.16), CPT (2.40), Exeter (3.23), Stanmore (3.28), Charnley (3.65), Corail (3.72), ABG II (4.30), Furlong HAC (5.08) and Furlong modular (7.14). A similar pattern of results was achieved when the standard error of variability of offset was analysed. We observed a wide variation in the ability of the femoral prosthesis templates to reproduce normal femoral offset. This variation was independent of the seniority of the observer. The templates of modern polished tapered stems with high modularity were best able to reproduce femoral offset. The current move towards digitisation of X-rays may offer manufacturers an opportunity to improve template designs in certain instances, and to develop appropriate computer software.


2018 ◽  
Vol 100 (6) ◽  
pp. 443-445
Author(s):  
A Moorhouse ◽  
G Giddins

The referral criteria used by the UK clinical commissioning groups for primary total hip replacement surgery appear inconsistent; the criteria rarely follow National Institute for Health and Care Excellence criteria. With established guidelines available, it is unclear why the clinical commissioning groups have referral criteia with less evidence base, without obviously addressing particular issues in their locality.


2019 ◽  
Vol 22 ◽  
pp. S218
Author(s):  
C.E. Edmiston ◽  
A.S. Chitnis ◽  
P. Nandwani ◽  
B. Chen ◽  
C.E. Holy ◽  
...  

2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  
R Ferguson ◽  
D Prieto-Alhambra ◽  
G Peat ◽  
K Jordan ◽  
J Valderas ◽  
...  

Abstract Introduction Limited data are available on the influence of multimorbidity on the outcomes of total hip replacement for patients with hip osteoarthritis. Thus, patients with multimorbidity and their clinicians across the UK are making decisions on whether or not to proceed with total hip replacement without clear information available on the potential risks and benefits. It is not known how such patients are currently managed. The aim of this study was to investigate the influence of multimorbidity on the likelihood of receiving total hip replacement in patients with hip osteoarthritis in the UK. Method A cohort study was performed, with cohort comprised of all patients over 65 years with a diagnosis of hip osteoarthritis recorded in Clinical Practice Research Datalink. Severity of multimorbidity burden was measured using four different scores (Charlson Comorbidity Index, Electronic Frailty Index, count of drugs prescribed, count of primary care interactions). The outcome was total hip replacement, evaluated using Kaplan-Meier survival and competing-risk analyses. Results 28,025 patients were included. 10,948 patients underwent total hip replacement. Increased multimorbidity burden was associated with decreased likelihood of undergoing surgery, irrespective of the method of scoring multimorbidity. Electronic Frailty Index had the largest difference between categories. Adjusted hazard ratio (‘severe multimorbidity versus ‘fit’) was 0.34 (95% CI 0.22, 0.51). Conclusions Patients with hip osteoarthritis and concurrent multimorbidity were up to two thirds less likely to undergo total hip replacement. Whether this difference in healthcare management is appropriate depends on to what extent multimorbidity influences the outcomes of total hip replacement.


2004 ◽  
Vol 14 (3) ◽  
pp. 155-162 ◽  
Author(s):  
R. Mootanah ◽  
P. Ingle ◽  
K. Cheah ◽  
J.K. Dowell ◽  
J.C. Shelton

1992 ◽  
Vol 30 (15) ◽  
pp. 57-60

This year over 40 000 people in the UK will have a total hip replacement and a further 15 000 patients will have replacement of a knee joint.1 This article reviews the progress made with these operations – which patients do they suit and how good are the results?


2013 ◽  
Vol 14 (1) ◽  
Author(s):  
Avril Drummond ◽  
Claire Edwards ◽  
Carol Coole ◽  
Catherine Brewin

Sign in / Sign up

Export Citation Format

Share Document